Aisling Capital is a leading investment firm that invests in products,
technologies, and global businesses that advance health.
Since 2000, Aisling Capital has raised over $1.6 billion in committed capital across three funds.
Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures.
The Aisling Capital team’s combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry.
888 7th Ave #30
New York, New York
10106 United States